Long-term survival after surgical management of neuroendocrine hepatic metastases. - Wikidata - wikimedia - TriplyDB

Long-term survival after surgical management of neuroendocrine hepatic metastases.

Long-term survival after surgical management of neuroendocrine hepatic metastases.

http://www.wikidata.org/entity/Q34528249

about

Liver Resection for Non-Colorectal Liver Metastases - Standards and Extended Indications Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids Management of patients with hepatic metastases from neuroendocrine tumors Surgical resection improves the outcome of the patients with neuroendocrine tumor liver metastases: large data from Asia Management Options for Advanced Low or Intermediate Grade Gastroenteropancreatic Neuroendocrine Tumors: Review of Recent Literature.Intramedullary spinal cord metastasis from pancreatic neuroendocrine tumor When should a liver resection be performed in patients with liver metastases from neuroendocrine tumours? A systematic review with practice recommendations Treatment of liver metastases in patients with neuroendocrine tumors: a comprehensive review.Neuroendocrine Liver Metastases and Orthotopic Liver Transplantation: The US Experience.Surgical treatment of neuroendocrine liver metastases Hepatic metastatic disease in pediatric and adolescent solid tumors.Liver-directed surgery of neuroendocrine metastases: What is the optimal strategy?Emerging approaches in the management of patients with neuroendocrine liver metastasis: role of liver-directed and systemic therapies.Ki67 score as a potential predictor in the selection of liver-directed therapies for metastatic neuroendocrine tumors: a single institutional experience Biliary tree gastrinomas in multiple endocrine neoplasia type 1 syndrome.Giant hepatic carcinoid: a rare tumor with a favorable prognosis.Current understanding and approach to well differentiated lung neuroendocrine tumors: an update on classification and management.Surgical treatment of liver metastases in neuroendocrine neoplasms.Surgical management of non-colorectal hepatic metastasis.Surgical management of noncolorectal cancer liver metastases.Role of surgery and transplantation in the treatment of hepatic metastases from neuroendocrine tumor.Curative versus palliative surgical resection of liver metastases in patients with neuroendocrine tumors: a meta-analysis of observational studies.Diagnosis and treatment of bronchopulmonary neuroendocrine tumours: State of the art.Impact of surgical margin clearance for resection of secondary hepatic malignancies.The Surgical Management of Small Bowel Neuroendocrine Tumors: Consensus Guidelines of the North American Neuroendocrine Tumor Society.Multimodal liver-directed management of neuroendocrine hepatic metastases Long term results of hepatic resection or orthotopic liver transplantation in patients with liver metastases from gastrointestinal neuroendocrine tumors.Principles of diagnosis and management of neuroendocrine tumours.Sunitinib malate as first-line treatment for an advanced, poorly differentiated pancreatic neuroendocrine tumor.Elevated Alkaline Phosphatase Prior to Transarterial Chemoembolization for Neuroendocrine Tumors Predicts Worse Outcomes.An overview of the surgical management of hepatic neuroendocrine metastases.Treatment of neuroendocrine tumor liver metastases."Cherry picking", a multiple non-anatomic liver resection technique, as a promising option for diffuse liver metastases in patients with neuroendocrine tumours.Outcome after resection and radiofrequency ablation of liver metastases from small intestinal neuroendocrine tumours.Intraarterial Liver-Directed Therapies: The Role of Interventional Oncology.Is there any role for minimally invasive surgery in NET?Neuroendocrine tumor of gallbladder with liver and retroperitoneal metastases and a good response to the chemotherapeutical treatment.Role of surgery in pancreatic neuroendocrine tumor.Surgical treatment of sporadic pancreatic neuroendocrine tumors: a state of the art review.Long term survival analysis of hepatectomy for neuroendocrine tumour liver metastases.

P2860

Q26765000-5274E681-04C8-4198-BAE2-CA4909B030D4 Q26996521-E06692E5-D0B7-4780-9BED-4E53D39D4FE6 Q27008832-43BA573C-C7D2-4210-BBE2-98498085A966 Q30884528-16C8D647-E58D-42F0-B90E-AD49CFDD4877 Q33737587-5EBCE9B6-2432-4774-BC4A-537296BA2DA0 Q34326748-78FB420D-87D7-4089-B98A-42DC32415248 Q34702055-8EDFD177-286C-4EF1-8E18-8EF7838FD06A Q35371197-A4FECE82-7B8A-4512-BB8A-27BE28A50A10 Q35664363-EA34A51F-8A6B-4185-B8D0-E73EBB9B41F2 Q35738752-60B49FB8-0FB0-4702-A59D-0C2097C184D1 Q35864811-5569987C-0C04-41E2-9ED7-31D0E8919770 Q36395882-F2166B1E-4919-4A90-AF34-44555C6C320F Q36512778-A0C61F0F-2696-4A45-A4D6-6C587854D79E Q36936986-D299499B-6AD9-4BBC-B24B-361DEE385AF4 Q37378933-40A2202C-8B29-4821-94CD-03C73E119B5E Q37599335-56C58137-4BD0-4F23-BCC1-60FB7D06707A Q37698605-C740F246-F6BB-4CC8-A187-1F390532A4B5 Q37982721-BF0F4708-E710-4B59-A301-D0A711CA0A4B Q38152298-A1A6A3CC-04B3-46DE-9F2C-A56971A888BE Q38224364-FA7DEF41-C483-41E9-BDB7-0A6F04BA2B27 Q38262113-C640F845-0AA0-4B40-9B70-3F4D27F7D3D7 Q38286002-C0F25C4A-F959-4381-B55D-6F82031865A2 Q38557054-B26EC289-4D90-4F52-8ADC-2ADFBCDB0375 Q38667823-B20E5964-1CE5-4413-A1DF-7E3934560072 Q38727852-E2A344BD-1899-4A98-8437-45934AD68364 Q38897797-5CDA28C3-E7E1-49B7-8A14-5EA0A8EB318E Q39144171-8789E5EA-FA41-498D-A9AD-4406225286AE Q39225250-C74CD366-5AB5-44F8-89F5-CA203F7CFFCB Q39411115-B8A5D6A5-6334-40E2-9C3E-3CADCB1A5450 Q41196104-F5E55D8A-4D17-4900-B144-E936753B203D Q42032092-E05F51F8-F809-4238-8F9D-CDEAB39DF3F0 Q42287138-34B6B6BF-5806-4A1E-9894-6F9865B81499 Q43475328-390A2D39-AF0E-46E2-9C7E-80C7F01E9F6F Q46383923-DA5D55A8-D8E9-4044-8EB3-2D6DC8C7D777 Q47101871-7552E78F-7F92-46C7-BF94-4C8D45600D3A Q47614835-F5F104EB-2FDC-4936-92A6-A57CC695A057 Q50169985-DC576B55-8161-4901-B00A-15EA213A9712 Q53831778-4A1F263C-BB37-48D2-B853-BA6770B4DD9F Q55192213-FE0929C2-5646-42D8-90AF-98AA6F58DB93 Q55411511-AD87D09A-BEA3-422D-A47B-97DE7CBD517F

P2860

Long-term survival after surgical management of neuroendocrine hepatic metastases.

http://www.wikidata.org/entity/Q34528249

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Long-term survival after surgical management of neuroendocrine hepatic metastases.

@ast

Long-term survival after surgical management of neuroendocrine hepatic metastases.

@en

Long-term survival after surgical management of neuroendocrine hepatic metastases.

@nl

type

label

Long-term survival after surgical management of neuroendocrine hepatic metastases.

@ast

Long-term survival after surgical management of neuroendocrine hepatic metastases.

@en

Long-term survival after surgical management of neuroendocrine hepatic metastases.

@nl

prefLabel

Long-term survival after surgical management of neuroendocrine hepatic metastases.

@ast

Long-term survival after surgical management of neuroendocrine hepatic metastases.

@en

Long-term survival after surgical management of neuroendocrine hepatic metastases.

@nl

P1433

Q34528249-3BD36603-E496-467E-B957-5073C5C9CD92

P1476

Q34528249-13654F16-9416-454B-9000-CDCE5D17C093

P2093

Q34528249-01A6E0DB-CB26-4563-A929-DD9AD19792C1

Q34528249-02179DC6-1EAD-41CC-93C4-9B1F50D1D4CB

Q34528249-260B9729-37DB-46B2-835C-260AD7643BF6

Q34528249-33D84B0C-12CB-4AF0-B684-878ADE943450

Q34528249-4F826DAB-B82D-4457-A0B5-95D74D69E6E3

Q34528249-B70CEC0A-CC2C-4BC2-9ADE-61D635CF18F0

Q34528249-F05CA5EF-C277-42C0-B1AF-E5BBE56B21F8

Q34528249-F27DCCA3-2098-483E-8C31-1AB18DD8FAA2

P2860

Q34528249-11C080B5-0EDB-4E08-B0E4-F4CB9979ED7C

Q34528249-12E36A8E-F994-4366-90EB-F6F30F2218C8

Q34528249-323F8FBB-F403-41C7-8CB3-AABE8DB72075

Q34528249-361EE872-C1A0-475C-B84A-FD2DCD4A169C

Q34528249-3D456997-BA69-4309-83D1-73EBB67A921B

Q34528249-82241EAA-EB23-4C0C-8CB3-871740AC5ABF

Q34528249-8D88C7F0-4FB2-491B-8872-7CFCDA7A4829

Q34528249-9B6405B9-8A6D-4392-9E1B-3A6823E57F33

Q34528249-C3552152-22DE-4E84-B0E8-1FD94DC8D489

Q34528249-D194A9C9-6232-4B5D-808A-47F9A4D125C1

P304

Q34528249-122BE762-4FA6-4FAE-9CE4-0B7E6A9B2622

P31

Q34528249-AAD627A3-8790-4CB7-89B7-62759E37C309

P356

Q34528249-11D3ECDC-B734-482A-BAF9-7E896378F0B5

P433

Q34528249-14259096-D833-4BFD-ACCD-F21F56A0C4DC

P478

Q34528249-0AC69CFF-BBA5-4EA6-B580-54B623D6A864

P50

Q34528249-3BC70748-5949-4279-ABEB-5E807378F3C7

P577

Q34528249-37072410-8DC8-436C-9A73-CA9BF2228905

P5875

Q34528249-932667F2-606E-4389-99DF-090CDCB11E0D

P698

Q34528249-5D4B5529-85D2-44AD-9C6C-DED8B922B209

P932

Q34528249-E55FC1B4-155A-4904-8B12-5CDDB2C244AE

P356

J.1477-2574.2010.00198.X

P1433

Hepato Pancreato Biliary

P1476

Long-term survival after surgical management of neuroendocrine hepatic metastases.

@en

P2093

Carmen C Solorzano

http://www.w3.org/2001/XMLSchema#string

Eddie K Abdalla

http://www.w3.org/2001/XMLSchema#string

Evan S Glazer

http://www.w3.org/2001/XMLSchema#string

Jennifer F Tseng

http://www.w3.org/2001/XMLSchema#string

Katherine A Willborn

http://www.w3.org/2001/XMLSchema#string

Ping Liu

http://www.w3.org/2001/XMLSchema#string

Steven A Curley

http://www.w3.org/2001/XMLSchema#string

Waddah Al-Refaie

http://www.w3.org/2001/XMLSchema#string

P2860

Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey

Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma.

Hepatic neuroendocrine metastases: chemo- or bland embolization?

Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases.

Treatment of liver metastases of carcinoid tumors.

Massive hepatic resection for the carcinoid syndrome.

Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group.

Gastrointestinal carcinoid tumors: factors that predict outcome.

Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study.

A 40-year analysis of 265 gastric carcinoids.

P304

427-433

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1477-2574.2010.00198.X

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Nicolas Vauthey

P577

2010-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45387760

http://www.w3.org/2001/XMLSchema#string

P698

20662794

http://www.w3.org/2001/XMLSchema#string

P932

3028584

http://www.w3.org/2001/XMLSchema#string